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Abstract: The aim of this study was to investigate the antimicrobial and antibiofilm activities of 10 different lactic acid bacteria (LAB)
strains isolated from local food sources of animal origin against 4 Enterobacter cloacae isolates obtained from clinical cases and determine
their adhesion potentials to intestinal epithelial cells. In this study, all Enterobacter cloacae isolates (P3, P4, P5, P7) identified with the
BD Phoenix automation system were detected to form biofilm with both Congo red agar and Microtiter plate methods. Amoxicillinclavulanate, cefuroxime, and ampicillin resistance was determined in all isolates. It was determined that LAB strains producing
exopolysaccharide (EPS) were able to colonize intestinal epithelial cells. It is noteworthy that LAB extracts were effective to inhibit
the biofilm formation of P3Ec, which had higher antibiotic resistance than those of other isolates. Antimicrobial effect of LAB extracts
on Enterobacter cloacae were also detected by both agar disc diffusion and well diffusion tests. In this study, all of the isolated LAB
strains (especially L. lactis, L. fermentum, and L. casei) are good candidates for controlling Enterobacter cloacae biofilm formation. These
findings indicate that L. lactis, L. fermentum, and L. casei can potentially be developed as novel antibiofilm agents.
Key words: Enterobacter cloacae, antimicrobial resistance, biofilm, lactic acid bacteria

1. Introduction
Biofilm refers to complex aggregate microorganism
communities that are bound to a surface, such as
Pseudomonas aeruginosa and Staphylococcus aureus. Some
bacteria are tightly embedded in the extracellular matrix
to form a biofilm. Biofilm not only makes microorganisms
resistant to adverse environmental conditions, but also
protects them from phagocytes and complement systems
[1,2]. Therefore, biofilm-forming microorganisms are
considered as the main cause of persistent hospital
infections, especially in immunocompromised individuals
[2]. Biofilm increases resistance to antibiotics by about 1000
times, making treatment more difficult [3]. Some bacteria,
including the genus Enterobacter, can move actively due
to the flagella they have. Motility helps food intake and
colony formation in bacteria. Bacteria including the
genus Enterobacter, are encapsulated lactose-fermenting
mobile bacteria that cause pneumonia and urinary tract
infections, especially with the use of contaminated devices
such as catheters and probes [4].

Diarrhea is an important factor in the formation of
many gastrointestinal tract pathologies such as irritable
bowel syndrome and chronic inflammation by causing
intestinal microflora imbalance [5]. One of the reasons
for intestinal microbiota imbalance is the unnecessary use
of antibiotics. Due to the biofilm formation of pathogenic
bacteria, the effectiveness of antibiotics in the treatment of
human and animal infections is a concern [6]. Currently,
the increase in the resistance of the members of the
family Enterobacteriaceae against antibiotics is one of the
major problems. One of the factors that cause bacterial
resistance is the biofilm generated by Enterobacter strains
[4]. The World Health Organization (WHO) describes
probiotics as live microorganisms that benefit the health
of the host when consumed in sufficient quantities. Lactic
acid bacteria (LAB) are the main source of probiotics
in nutrients. Probiotics must survive under stressful
conditions of the gastrointestinal tract by tolerating acid,
bile, and gastric enzymes and should be colonized by
binding into the intestinal epithelial cells. Furthermore,
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probiotics must have antimicrobial effects against
pathogenic microorganisms [7].
Studies have shown that LAB support the digestion
and assimilation of nutrients [8], modulate the immune
system [9], remove toxic substances, and prevent the
reproduction or invasion of parasites and pathogenic
bacteria to prevent gastrointestinal infections [10].
Recently, the use of probiotics has been considered as a
natural alternative to antibiotic supplements [7]. However,
studies on enteropathogenic bacteria inhibited by LAB
are very few. Furthermore, Cui et al. [7] have reported
that studies on the impact of LAB on enteropathogenic
bacterial biofilm have been neglected.
The aim of this study is to determine the antimicrobial
and antibiofilm effect of LAB isolated from local food
sources against Enterobacter cloacae isolated from animals
and determine their adhesion potential to intestinal
epithelial cells.
2. Materials and methods
2.1. Microorganisms used in the study
Ten LAB isolates were defined in terms of species with
universal primers and 16S rRNA sequence analysis
previously from local meat and dairy products. The
LAB were obtained from the culture collection of Afyon
Kocatepe University, Technical Vocational School of Bayat
(Table 1).
Animal-derived pathogen strains were obtained from
the culture collection consisting of samples from the field
brought to the Animal Hospital and Research Centre
and Necropsy Laboratory at the Faculty of Veterinary
Medicine of Afyon Kocatepe University. They included
cow mastitis (P7), horse runny nose (P3, 5), and canine

abdominal swab (P4) and they were identified in the
Medical Microbiology Bacteriology Laboratories of the
Eskişehir Osmangazi University Faculty of Medicine using
the BD Phoenix automation system.
2.2. Detection of biofilm formation in pathogen isolates
2.2.1. Congo red agar method (qualitative method)
The isolates were firstly kept in Congo red agar medium
[11] at 37 °C for 24 h, then they were incubated at 25 °C
for 48 h. Red, black, rough, dry, and transparent colonies
in the medium were evaluated as biofilm (slime)-positive
while pinkish red, flat, and central dark colonies were
evaluated as biofilm-negative [12].
2.2.2. Quantitative detection of biofilm formation
Enterobacter strains were incubated at 37 °C for 24 h in
nutrient broth (NB). Subsequently, microorganism culture
of 150 μL was transferred to a 96-well microtiter plate.
These plates were reincubated at 37 °C for 24 h. After
incubation, the liquid medium was poured, the wells were
washed 3 times with distilled water, and crystal violet
solution of 150 μL [0.5% (v/v)] was added into the wells.
After being kept in ambient temperature for 45 min the
wells were washed again with distilled water 3 times.
Then 150 µL of ethanol and acetic acid (95:5) was added
and left to stand for 10 min to dissolve the dye. After this
step, 100 μL was taken from each well and transferred
to a new microtiter plate. The absorbance values of each
well at 570 nm were determined using ELISA (Thermo
Multiskan Go). P. aeruginosa ATCC 11778 strain, which is
known to generate biofilm, was used as a positive control
and microorganism-free medium was used as a negative
control. Excessive absorbance values compared to the
negative control indicate that microorganisms can form
biofilm [13,14].

Table 1. LAB 16S rRNA results.
Isolates*

16S rRNA analysis results

Number of
compared bases

(%) Similarity

L1

Lactococcus lactis subsp. lactis strain CAU9932 (Sequence ID: MF098094.1)

1413

98%

L2

Lactobacillus fermentum strain CAU:3341[Sequence ID: MF354239.1]

1402

98%

L3

Enterococcus faecalis strain FC1377 [Sequence ID: MG871229.1]

1522

99%

L4

Lactobacillus casei strain 090 [Sequence ID: JN560917.1]

1443

99%

L5

Lactobacillus plantarum strain Lb17 [Sequence ID: MG825687.1]

1373

100%

L6

Enterococcus faecium strain CAU2799 [Sequence ID: MF425224.1]

1335

99%

L7

Lactobacillus curvatus strain 1TP06-BL06 [Sequence ID: MG031211.1]

1470

99%

L8

Enterococcus durans strain CAU6145 [Sequence ID: MF424830.1]

1407

99%

L9

Lactococcus garvieae strain CAU6586 [Sequence ID: MF108375.1]

1396

94%

L10

Enterococcus faecium strain CAU10244 [Sequence ID: MF429017.1]

1377

99%

*Lactic acid bacteria were isolated in project numbers AKÜ BAP 17. MYO. 07 and AKÜ BAP 17.SAĞ.BİL.06.
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2.3. Swimming, swarming, and twitching motilities of
Enterobacter spp.
In order to determine the motility status in pathogenic
strains, swarming tests on NB medium according to the
method used by Rashid and Kornberg [15] and swimming
and twitching motility tests according to Deziel et al. [16]
were carried out.
2.4. Determination of EPS production of LAB
To produce the EPS of LAB, the method developed by
Marshall and Rawson [17] was used. For this, LAB isolates
were activated by incubation in nutrient broth for 24 h
at 37 °C and subsequently equal amounts of the samples
brought to 0.5 McFarland turbidity (approximately 1 to 4
× 108 CFU/mL) were transferred into NB medium of 5 mL
and incubated for 20 h at 37 °C. After incubation, cultures
of 1 mL were taken and distributed into Eppendorf
tubes, which were incubated in a water bath at 100 °C
for 10–15 min. Trichloroacetic acid (TCA; 85%) at a rate
of 0.17% was added to the samples that were cooled at
room temperature and were centrifuged. The supernatant
obtained was placed into another Eppendorf tube and the
same amount of ethanol was added, and the content was
centrifuged. After repeating this process, EPS production
was determined with phenol sulfuric acid method and by
reading the absorbance values at 490 nm. This test was
repeated 3 times. The results were evaluated according to
the established glucose standard curve.
2.5. Determination of antibacterial effects of lactic acid
bacteria
2.5.1. Preparation of lactic acid culture filtrates
In order to determine the antimicrobial effects of LAB
isolates, an extract from each isolate was planted in De
Man-Rogosa-Sharpe (MRS) broth medium and incubated
at 37 °C for 24 h, after which the plasma was centrifuged
at 8000 rpm for 10 min (4 °C). Culture supernatants
were collected into sterile flacon tubes. The supernatants
obtained were drawn with sterile injectors and filtered
through a sterile membrane filter with a 0.2-μm pore
diameter, and the filtrates were used to determine the
antimicrobial activity [18].
2.5.2. Determination of antimicrobial activity of lactic
acid culture filtrates
The antimicrobial effect of culture filtrates was investigated
by using the agar well diffusion test and agar disc diffusion
method. Suspensions were prepared from the 24-h cultures
of Enterobacteriaceae strains used in the study in the agar
medium, equivalent to 0.5 McFarland turbidity in distilled
water, for the agar diffusion test. The bacterial suspensions
were dispersed into the NA medium using a sterile swab
stick. The wells were drilled with a sterile agar drill of 6
mm in diameter. Lactic acid culture filtrates of 100 μL were
added to the wells [18]. For the agar disc diffusion method,

Mueller Hilton agar (MHA) was applied according to the
standard method by impregnating empty antibiotic discs
with a filtrate of 20 µL [19]. In both methods, after 24 h of
incubation at 37 °C, the impact of antimicrobial activity
was evaluated according to the presence of a zone of
inhibition.
2.6. Determination of antibiofilm effect of LAB extracts
The isolates were planted on appropriate media and
incubated at 37 °C for 24 h. Subsequently LAB extracts
were added to the cultures and transferred to ELISA plates,
which were incubated at 37 °C for 24 h.
The effect of LAB on antibiofilm was determined
according to the method by Thenmozhi et al. [20]. Briefly,
the LAB were incubated in MRS media at 37 °C for 48 h
and then centrifuged at 4000 rpm, and filtered through
a membrane filter. Cell-free supernatant (CFS) was
extracted twice with the same volume of ethyl acetate [21].
Equal amounts of extracts were dissolved in distilled water
and diluted to one half of the previous concentration 3
times, and each dilution was used to detect the effect of
antibiofilm. The isolates were planted on appropriate media
and incubated at 37 °C for 24 h. Subsequently LAB extracts
were added to the cultures and transferred to ELISA plates,
which were incubated at 37 °C for 24 h. After incubation,
the liquid medium was poured and the wells were washed
3 times with distilled water. Crystal violet solution at
0.5% was dispersed into the wells and incubated at room
temperature. The wells were assayed in ELISA at 570 nm
and biofilm inhibitory effects were determined [13,14].
The antibiofilm activity of the extracts was calculated with
the percent reduction formula.
% Inhibition = (A control – A sample / A control) ×
100
A control: Absorbance value containing only
Enterobacter strains
A sample: Absorbance value with LAB extracts (LAB +
Enterobacter) added
3. Results
According to the BDPhoenix bacterial identification and
antibiogram sensitivity test, isolates P3, P4, P5, and P7
were defined as Enterobacter cloacae. The sensitivity test
results are given in Table 2.
All isolates were resistant to amoxicillin-clavulanate
and ampicillin. The highest antibiotic resistance was
found in strain P3. This strain is resistant to amoxicillinclavulanate, ampicillin, cefepime, ceftriaxone, cefuroxime,
and ertapenem antibiotics, and moderately sensitive to
meropenem and tigecycline antibiotics.
3.1. Detection of biofilm formation in Enterobacter
cloacae isolates
In both methods, it was determined that Enterobacter
cloacae isolates formed biofilm (Figure 1 and Table 3). The
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Table 2. The results of antibiotic susceptibility testing of E. cloacae.
Microorganism
P3

P4

P5

P7

Antibiotic

MIC

MIC

MIC

MIC

Amikacin

≤4

S

≤4

S

≤4

S

≤4

S

Amoxicillin-clavulanate

>32/2

R

>32/2

R

>32/2

R

>32/2

R

Ampicillin

>8

R

>8

R

>8

R

>8

R

Aztreonam

≤1

S

≤1

S

≤1

S

≤1

S

Cefepime

>8

R

≤1

S

≤1

S

≤1

S

Ceftazidime

≤0.5

S

≤0.5

S

≤0.5

S

≤0.5

S

Ceftriaxone

>4

R

≤0.5

S

≤0.5

S

≤0.5

S

Cefuroxime

>8

R

8

R

>8

R

>8

R

Ciprofloxacin

≤0.125

S

≤0.125

S

≤0.125

S

≤0.125

S

Ertapenem

>1

R

≤0.25

S

≤0.25

S

≤0.25

S

Gentamicin

≤1

S

≤1

S

≤1

S

≤1

S

Imipenem

1

S

≤0.25

S

≤0.25

S

≤0.25

S

Meropenem

4

I

≤0.125

S

≤0.125

S

≤0.125

S

Netilmicin

1

S

1

S

1

S

1

S

Piperacillin

≤4

S

≤4

S

≤4

S

≤4

S

Piperacillin-tazobactam

≤4/4

S

≤4/4

S

≤4/4

S

≤4/4

S

Tigecycline

2

I

1

S

1

S

1

S

Trimethoprim-sulfamethoxazole

≤ 1/19

S

≤1/19

S

≤1/19

S

≤1/19

S

MIC: Minimum inhibition concentration, S: Susceptible, I: Intermediate, R: Resistant.

Figure 1. Biofilm-positive P5 and P6 isolates with Congo red agar method.

data obtained as a result of the microtitration plate method
are compared with the negative control in Table 3.
The highest absorbance was found for P3 as 1.047. This
was followed by P4 (0.895), which we had determined
previously to be highly antibiotic resistant. The results
indicate that biofilm formation may be responsible for the
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antibiotic resistance of P3. The formation of biofilm in the
isolates and motility test results show that the isolates can
swim, swarm, and twitch (Table 3).
3.2. EPS production of lactic acid isolates
A glucose standard curve was prepared by using a glucose
solution of 1.25–100 mg/mL to calculate the EPS amounts

KENAR et al. / Turk J Vet Anim Sci
generated by LAB (Figure 2). The equation y = 0.0482x
+ 0.4242 was used to express the EPS amount (mg/mL)
corresponding to the absorbance (Table 4).
The highest EPS production (49.31 mg/mL) was
found in the Enterococcus faecalis (L3) strain, followed by
Lactobacillus plantarum (L5) with EPS of 34.02 mg/mL
and Lactobacillus fermentum (L2) with EPS of 33.77 mg/
mL.
3.3. Antimicrobial effect of LAB extracts
The results of both agar disc diffusion and well diffusion
tests indicate that the tested amounts of the extracts have
antimicrobial effect (Table 5). It was determined that L1,
L4, L6, and L10 isolates had antimicrobial effects by both
agar disk diffusion test and agar well diffusion test on
Enterobacter cloacae isolates.
3.4. Antibiofilm effect of LAB extracts
The inhibition percentage values of LAB extracts on
Enterobacter cloacae isolates are shown in Table 6.

It has been determined that diluted extracts at a ratio
of 1:1 prepared from isolates of Lactococcus lactis (L1),
Lactobacillus casei (L4), Lactobacillus plantarum (L5),
Enterococcus faecium (L6), and Lactobacillus curvatus
(L7) inhibit the formation of biofilm in all tested isolates.
The extract of Lactococcus lactis (L1) diluted at a ratio of
1:1 was detected to inhibit the biofilm formation of the
P3Ec isolate, which had the highest antibiotic resistance
at 91.97%. Even dilution of this extract at the ratio of 1:8
inhibited biofilm formation of the same isolate at a level of
84.24%. The extracts from Lactobacillus fermentum (L2),
Enterococcus faecalis (L3), and Lactococcus garviae (L9)
isolates did not inhibit the biofilm formation of the P4Ec
isolate, whereas diluted extract at a ratio of 1:1 prepared
from Lactococcus casei (L4) reduced the biofilm formation
of the same isolate by 91.91%.
It was determined that all LAB extracts among the
tested isolates inhibited biofilm formation at rates ranging

Table 3. The formation of biofilm in the isolates and motility test results (mm).
Motility (mm)
Microorganism

Biofilm formation

Swarming

Swimming

Twitching

Average absorbance
(570 nm) (SD)

P3Ec

11

10

13

1.047 (±0.53)

P4 Ec

12

13

14

0.895 (±0.22)

P5 Ec

10

11

12

0.889 (±0.25)

P7 Ec

13

12

13

0.769 (±0.28)

P. aeruginosa ATCC 11778

13

7

10

0.204 (±0.12)

NC

-

-

-

-

NC: Negative control, Ec: E. cloacae SD: Standard deviation.

Absorbance (490 nm)

6

y = 0,0482 × + 0,4242
R² = 0,9362

5
4
3
2
1
0

0

20

40

60

80

100

120

Glucose (mg /mL)
Figure 2. Glucose standard curve.
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Table 4. EPS production in LAB.
Microorganism

EPS (mg/mL)

L1 (Lactococcus lactis)

31.44

L2 (Lactobacillus fermentum)

33.77

L3 (Enterococcus faecalis)

49.31

L4 (Lactobacillus casei)

26.28

L5 (Lactobacillus plantarum)

34.02

L6 (Enterococcus faecium)

14.68

L7 (Lactobacillus curvatus)

2.95

L8 (Enterococcus durans)

4.25

L9 (Lactococcus garviae)

7.44

L10 (Enterococcus faecalis)

6.15

to determine the antibiotic susceptibility of enterococci,
and virulence genes (asa1, ccf, gelE, esp, CylA, ace, and
agg) have been determined [28]. In Enterobacter species,
both chromosomally encoded resistance to antibiotics and
resistance carried by plasmids and transferred between
species have been detected. Due to the increased empirical
use of beta-lactam antibiotics, the development of resistance
to these antibiotics increases and multiple antibioticresistant strains are manifested. Although antibiotics seem
to be the most effective drugs for treatment, studies are
needed to investigate glycopeptides and new antimicrobial
agents [28]. Among the Enterobacter species, E. cloacae is
one of the most common infection agents. Many studies
have been conducted to investigate the resistance status of
the Enterobacter species.
Willis et al. [29] reported that 48% of the Enterococcus
strains isolated from foals of 0–30 days old displayed
multiple antimicrobial resistance. In another study, a total
of 105 enterococci were isolated from mastitic bovine
milk samples and, in general, enterococci were sensitive
to ampicillin, gentamicin, and vancomycin and resistant
to tetracycline, penicillin, erythromycin, cephalothin,
gentamicin, and vancomycin [27].
Song et al. [30] found that 27.7% of the species
belonging to the family Enterobacteriaceae producing
94 expanded-spectrum beta-lactamases (ESBL) were
sensitive to ceftazidime, 39.4% to aztreonam, and 75.5% to
cefepime. In another study, Poulou et al. [31] reported that
13.6% of the 162 isolates of Enterobacter spp. generating
ESBL were found to be susceptible to ceftazidime, 28.4%
to cefepime, and 19.8% to aztreonam.
In this study, Enterobacter cloacae strains were
determined to be resistant to amoxicillin-clavulanate,

between 17.24% and 91.97% in the tested P3Ec strain with
the highest antibiotic resistance.
4. Discussion
Bacteria in the genus Enterococcus are the causative agent
of both human and veterinary sepsis [22,23]. They cause
difficulties in the clinic due to the variety of antibiotic
resistance manifested in veterinary medicine [24].
Recently, the prevalence of enterococci has been found
to be an increasing cause of sepsis in foals during the last
30 years [22]. Furthermore, enterococci species can cause
many economically significant animal diseases including
bovine mastitis [25]. The incidence of enterococci as an
etiologic agent of bovine mastitis was found to be as high
as 21.2% [26,27]. Therefore, studies have been performed
Table 5. The antimicrobial effect of LAB extracts.

Microorganism

Agar disk diffusion test results (mm)
L1

L2

L3

L4

L5

L6

L7

L8

L9

L10

P3 Ec

11

14

9

14

9

10

-

12

12

13

P4 Ec

8

9

9

10

-

10

-

-

-

9

P5 Ec

10

10

13

12

10

8

9

8

9

P7 Ec

11

12

12

10

10

11

-

-

-

13

P. aeruginosa ATCC 11778

-

10

13

-

-

11

-

-

-

-

P3 Ec

14

16

16

13

12

14

17

19

15

13

P4 Ec

14

-

-

9

14

9

16

20

-

15

P5 Ec

9

13

14

13

-

11

15

15

9

22

P7 Ec

16

14

15

14

13

17

23

25

14

16

P. aeruginosa ATCC 11778

11

13

11

10

13

13

20

19

11

15

11

Agar well diffusion test results (mm)
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Table 6. Inhibition (%) of biofilm of LAB extracts
Diluted LAB
extract

Inhibition %
P3Ec

Lactococcus lactis (L1)
1/1
91.97
1/2
90.44
1/4
90.16
1/8
84.24
Lactobacillus fermentum (L2)
1/1
86.15
1/2
85.38
1/4
74.49
1/8
74.11
Enterococcus faecalis (L3)
1/1
68.20
1/2
54.15
1/4
49.57
1/8
41.45
Lactobacillus casei (L4)
1/1
80.20
1/2
79.68
1/4
38.63
1/8
17.24
Lactobacillus plantarum (L5)
1/1
65.57
1/2
52.36
1/4
36.22
1/8
20.16
Enterococcus faecium (L6)
1/1
51.95
1/2
43.45
1/4
18.59
1/8
Lactobacillus curvatus (L7)
1/1
89.39
1/2
88.72
1/4
88.53
1/8
88.06
Enterococcus durans (L8)
1/1
84.81
1/2
83.28
1/4
82.90
1/8
81.18
Lactococcus garviae (L9)
1/1
87.58
1/2
87.10
1/4
84.24
1/8
81.27
Enterococcus faecalis (L10)
1/1
91.21
1/2
90.06
1/4
79.56
1/8
78.03

P4Ec

P5Ec

P7Ec

86.48
73.29
38.10
-

84.02
77.72
65.69
30.70

82.31
80.36
38.36
-

-

80.53
45.10
9.11
-

73.21
70.74
-

-

72.89
38.92
24.74
12.71

82.96
67.75
60.59
36.11

91.91
42.90
10.94
-

79.52
48.48
17.66
16.64

81.40
80.23
60.59
30.65

72.51
54.97
32.73
-

76.04
55
32.39
-

79.45
73.73
55.65
38.49

72.84
48.15
20.22
13.96

81.21
37.23
21.14
-

81.40
76.98
56.17
29.51

80.22
61.45
36.98
-

84.36
82.78
75.14
74.24

80.10
79.58
26.65
15.73

33,96
-

62.42
33.74
-

85.26
78.34
56.22
26.83

-

34.19
28.34
27.44
-

17.03
-

34.18
-

29.80
24.74
22.72
12.24

21.45
-

cefuroxime, and ampicillin antibiotics and sensitive
to amikacin, aztreonam, ceftazidime, ciprofloxacin,
gentamicin,
imipenem,
netilmicin,
piperacillintazobactam, trimethoprim-sulfamethoxazole antibiotics.
The highest antibiotic resistance was observed in P3Ec
(amoxicillin-clavulanate, ampicillin, cefepime, ceftriaxone,
cefuroxime, ertapenem) (Table 2). Many Enterobacter
spp. form biofilm [4,32,33]. Sabir et al. [34] investigated
the biofilm formation of pathogens causing urinary tract
infection and their resistance to antibiotics. They reported
that 73.4% of the isolates formed biofilms and the highest
biofilm production among the isolated pathogens was
reported for ampicillin-resistant Enterobacter cloacae
(87.5%).
Fighting infections caused by Enterobacter species
is becoming increasingly difficult. The morbidity and
mortality rates of resistant Enterobacter-induced infections
are 2–3 times higher than that of normal infections [35].
Biofilm formation causes the treatment of infections to
become more difficult and increases treatment costs [36].
Therefore, in recent years, researchers have started working
on the advantages of some beneficial microorganisms in
order to eliminate the harmful effects of biofilm. In their
study Slama et al. [37] isolated probiotic Lactobacillus
strains from fermented foods and determined that
the extracts were able to eliminate the formation of L.
monocytogenes biofilm significantly. In another study, Cui
et al. [7] investigated the antibiotic activity of LAB strains
which were isolated from traditional cheeses against
enteropathogenic bacteria. Twelve out of 321 isolates were
identified with antibiofilm activity against Staphylococcus
aureus CMCC26003 and Escherichia coli CVCC230.
It was determined that Enterobacter cloacae isolates
were mobile and formed biofilm in this study (Table
3). The highest biofilm formation was found for P3,
which we determined previously to be highly antibiotic
resistant. The results indicate that biofilm formation may
cause the antibiotic resistance. It was observed that the
biofilm formations of E. cloacae isolates were inhibited
by all the L1, L4, L5, L6, and L7 isolates tested with the
1:1 concentration. In particular, it is noteworthy that 1:1,
2, and 3 concentration extracts of all LAB inhibited the
biofilm formation of P3Ec which had the highest antibiotic
resistance among the tested isolates. It was determined
that Lactococcus lactis extract diluted at a rate of 1:1 was
the LAB extract which inhibited the formation of biofilms
more than the control (91.97% at P3Ec). The highest levels
of inhibition of biofilm for the P5Ec and P7Ec isolates were
detected for the extracts of Lactobacillus curvatus (L7), and
Enterococcus durans (L8) at a rate of 1:1, respectively.
It is known that LAB produce an antimicrobial peptide
called bacteriocin [38]. LAB members play an important
role in reducing the production of toxins in pathogenic
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bacteria with the bacteriocins they produce. Therefore,
there is an increase in studies on the use of LAB both in
food preservation and in the prevention of pathogenic
bacteria production [39,40]. Santos et al. [41] described
bacteriocins as antimicrobial and antibiotic agents in
their study. The antimicrobial spectrum of MccC7-C51
bacteriocin was investigated and its action against bacterial
strains was noted.
In our study, both the agar disc diffusion and the well
diffusion tests show that LAB extracts have an antimicrobial
effect on Enterobacter cloacae. The differences between the
results of agar disc diffusion and well diffusion tests are
due to the fact that the amount of extract used in the agar
disc diffusion method (20 μL) was less than that used in
the well diffusion test (100 μL).
Another substance synthesized by LAB are EPSs. These
synthesized EPSs protect the bacterium against incidents
such as phagocytosis and protozoa breakdown, phage
effect, antibiotics, and osmotic pressure [42]. Studies have
been carried out to determine whether probiotic bacteria
such as Lactobacillus spp. produce EPS or not. As an
example, Tallon et al. [43] investigated the EPS production
of the Lactobacillus plantarum EP56 strain isolated from
maize and found that EPS production was 0.114 mg/mL.
In their study, Looijesteijn et al. [44] reported that bacteria
were protected against bacteriophages, metal ions, and
various antimicrobial agents such as lysozyme by the EPSs
generated by Lactococcus lactis subsp. cremoris NZ4010.
In our study, we determined the adhesion capacity and
colonization of the LAB strains into intestinal epithelial
cells. It was determined that Enterococcus faecalis (L3)
produced the most EPS (49.31 mg/mL), followed by
Lactobacillus plantarum (L5) with 34.02 mg/mL EPS
and Lactobacillus fermentum (L2) with 33.77 mg/mL
EPS. The Lactococcus lactis CNM81 strain isolated from
raw milk was found to have a potential antibiofilm effect
on Salmonella typhimurium SL1344 [45]. Similarly,
Lactococcus lactis (L1) isolates in this study were found to
inhibit biofilm formation in all isolates including the P3Ec
strain, which has the highest antibiotic resistance with a
1:1 concentration. In addition, even the lowest dilution
of Lactococcus lactis (L1) (1:8) was determined to inhibit
biofilm formation of this strain at a rate of 84.24%. All
Lactobacillus casei (L3), Lactobacillus plantarum (L5),
Enterococcus faecium (L6), and Lactobacillus curvatus (L7)
exhibited antibiofilm activity on all isolates tested with
the 1:1 concentration. As the dilution rate increased, the
antibiofilm effect decreased and/or was eliminated.
Enterococcus spp. LAB are among important
bacteria in terms of both food microbiology and clinical
microbiology [46,47]. In addition to its capacity to
improve the organoleptic properties of some foods,
Enterococcus faecalis is used as a starter culture in the
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maturation of some fermented milk and meat products
together with other LAB because of its lipolytic and
esterolytic activity, and its capacity to benefit from citrate
and synthesize volatile aromatic compounds. Enterococci
are used as probiotics in human and animal intestinal
flora to ensure microbial balance [48]. Furthermore, some
pharmaceutical products containing Enterococcus strains
as a probiotic culture are used in the clinical treatment
of humans [47]. These probiotic preparations are used
to treat gastroenteritis by improving the gastrointestinal
balance and prevent enteric diseases in animals [49]. Two
species in the genus Enterococcus have been reported as
having probiotic properties, namely Enterococcus faecium
and Enterococcus faecalis [50]. According to our data,
Lactobacillus fermentum (L2), Lactobacillus casei (L3),
Lactobacillus plantarum (L5), and Lactobacillus curvatus
showed similar effects with Enterococcus faecium (L6).
EPSs produced by LAB play an important role in the food
and health industries. In previous studies, it was stated that
EPSs regulated the immune system, lowered cholesterol,
and had antiulcer and antitumor effects [51]. EPS forms a
bond between intestinal epithelial tissue and bacteria in the
intestinal flora. Therefore, the strains capable of producing
EPSs are capable of adhering to the epithelium at a high
capacity, so the production of EPS is an important factor
that enables probiotics to colonize the intestinal surface
and maintain viability [52]. It was determined that the LAB
isolates used in our study were able to colonize the EPS
intestinal epithelial cells. Because of the resistance against
antibiotics in the last years, scientists have been looking
for alternative sources for treatment. The antimicrobial
and antibiofilm compounds produced by the LAB used in
this study can be used in the treatment of many diseases,
and the use of antibiotics can be decreased this way. It was
determined that the LAB isolates used in our study were
able to colonize the EPS intestinal epithelial cells.
In conclusion, in this study, the antimicrobial and
antibiofilm activities of foodborne LAB were investigated
against Enterobacter cloacae strains of animal origin
and their adhesion potential to the intestinal epithelial
cells was determined. Based on the data obtained in this
study, almost all of the LAB isolates (especially L. lactis, L.
fermentum, and L. casei) strains are good candidates for
controlling Enterobacter cloacae biofilm formation. These
findings indicate that L. lactis, L. fermentum, and L. casei
can potentially be developed as novel antibiofilm agents.
However, further in vitro and in vivo studies of these LAB
strains should be conducted.
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